1
|
Larivière L, Krüger JE, von Hirschheydt T, Schlothauer T, Bray-French K, Bader M, Runza V. End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparations. Int J Pharm X 2023; 5:100157. [PMID: 36687375 PMCID: PMC9850176 DOI: 10.1016/j.ijpx.2023.100157] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Revised: 12/23/2022] [Accepted: 01/01/2023] [Indexed: 01/04/2023] Open
Abstract
Antibody-based T cell-activating biologics are promising therapeutic medicines being developed for a number of indications, mainly in the oncology field. Among those, T cell bispecific antibodies are designed to bind one tumor-specific antigen and the T cell receptor at the same time, leading to a robust T cell response against the tumor. Although their unique format and the versatility of the CrossMab technology allows for the generation of safer molecules in an efficient manner, product-related variants cannot be completely avoided. Therefore, it is of extreme importance that both a manufacturing process that limits or depletes product-related impurities, as well as a thorough analytical characterization are in place, starting from the development of the manufacturing cell line until the assessment of potential toxicities. Here, we describe such an end-to-end approach to minimize, quantify and control impurities and -upon their functional characterization- derive specifications that allow for the release of clinical material.
Collapse
Key Words
- Antibody manufacturing process
- CE-SDS, capillary electrophoresis‑sodium dodecyl sulfate
- CRS, cytokine release syndrome
- ELISA, enzyme-linked immunosorbent assay
- End-to-end approach
- Fc, fragment crystallizable
- Functional characterization
- GMP, good manufacturing process
- HIC, hydrophobic interaction chromatography
- HMW, high molecular weight (species)
- IEX, ion exchange chromatography
- PBS, phosphate buffer saline
- Product-related impurities control
- SEC, size-exclusion chromatography
- SPR, surface plasmon resonance
- TAA, tumor-associated antigen
- TCB, T cell bispecific
- TCR, T cell receptor
Collapse
Affiliation(s)
- Laurent Larivière
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg 82377, Germany
| | - Julia Eva Krüger
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg 82377, Germany
| | - Thomas von Hirschheydt
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg 82377, Germany
| | - Tilman Schlothauer
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg 82377, Germany
| | - Katharine Bray-French
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel 4058, Switzerland
| | - Martin Bader
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg 82377, Germany
| | - Valeria Runza
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg 82377, Germany,Corresponding author.
| |
Collapse
|
2
|
Kalyani DC, Reichenbach T, Keskitalo MM, Conrad J, Aspeborg H, Divne C. Crystal structure of a homotrimeric verrucomicrobial exo- β-1,4-mannosidase active in the hindgut of the wood-feeding termite Reticulitermes flavipes. J Struct Biol X 2021; 5:100048. [PMID: 34195602 DOI: 10.1016/j.yjsbx.2021.100048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Revised: 05/10/2021] [Accepted: 05/10/2021] [Indexed: 11/29/2022]
Abstract
First structure of a glycoside hydrolase from a bacterial symbiont isolated from the digestive tract of the notorious termite pest Reticulitermes flavipes. First example of a GH5 glycoside hydrolase that features a GH42-type homotrimeric structure. High exo-type specificity for the terminal ®-1,4-mannosidic linkages in mannooligosaccharides and unsubstituted®-mannans. Verrucomicrobial gut symbiont with high potential for hemicellulose degradation.
The termite Reticulitermes flavipes causes extensive damage due to the high efficiency and broad specificity of the ligno- and hemicellulolytic enzyme systems produced by its symbionts. Thus, the R. flavipes gut microbiome is expected to constitute an excellent source of enzymes that can be used for the degradation and valorization of plant biomass. The symbiont Opitutaceae bacterium strain TAV5 belongs to the phylum Verrucomicrobia and thrives in the hindgut of R. flavipes. The sequence of the gene with the locus tag opit5_10225 in the Opitutaceae bacterium strain TAV5 genome has been classified as a member of glycoside hydrolase family 5 (GH5), and provisionally annotated as an endo-β-mannanase. We characterized biochemically and structurally the opit5_10225 gene product, and show that the enzyme, Op5Man5, is an exo-β-1,4-mannosidase [EC 3.2.1.25] that is highly specific for β-1,4-mannosidic bonds in mannooligosaccharides and ivory nut mannan. The structure of Op5Man5 was phased using electron cryo-microscopy and further determined and refined at 2.2 Å resolution using X-ray crystallography. Op5Man5 features a 200-kDa large homotrimer composed of three modular monomers. Despite insignificant sequence similarity, the structure of the monomer, and homotrimeric assembly are similar to that of the GH42-family β-galactosidases and the GH164-family exo-β-1,4-mannosidase Bs164 from Bacteroides salyersiae. To the best of our knowledge Op5Man5 is the first structure of a glycoside hydrolase from a bacterial symbiont isolated from the R. flavipes digestive tract, as well as the first example of a GH5 glycoside hydrolase with a GH42 β-galactosidase-type homotrimeric structure.
Collapse
Key Words
- 4-mannosidase
- CAZy, Carbohydrate-Active enZymes database
- CMC, carboxymethyl cellulose
- Crystal structure
- DP, degree of polymerization
- EDTA, ethylenediaminetetraacetic acid
- ESI-MS, electrospray ionization mass spectrometry
- Electron cryo-microscopy
- Exo-β-1
- Fuc, fucopyranoside
- GH, glycoside hydrolase
- Gal, galactopyranoside
- Glc, glucopyranoside
- GlcNAc, N-acetyl glucosamine
- Glycosyl hydrolase family 5
- HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
- HPAEC-PAD, High Performance Anion Exchange Chromatography and Pulsed Amperometric Detection
- IPTG, β-D-1-thiogalactopyranoside
- LBG, locust bean gum
- MOS, mannooligosaccharides
- MWCO, molecular weight cut-off
- Man, mannopyranoside
- Op5Man5, exo-β-1,4-mannosidase from Opitutaceae bacterium strain TAV5
- Opitutaceae
- Reticulitermes flavipes
- SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis
- SEC, size-exclusion chromatography
- TCEP, tris (2-carboxyethyl) phosphine hydrochloride
- TLC, thin-layer chromatography
- Termite hindgut
- Verrucomicrobia
- Xyl, xylopyranoside
- cryo-EM, electron cryo-microscopy
- pNP, p-nitrophenyl
Collapse
|
3
|
Gerner L, Munack S, Temmerman K, Lawrence-Dörner AM, Besir H, Wilmanns M, Jensen JK, Thiede B, Mills IG, Morth JP. Data for the co-expression and purification of human recombinant CaMKK2 in complex with calmodulin in Escherichia coli. Data Brief 2016; 8:733-40. [PMID: 27508226 PMCID: PMC4950174 DOI: 10.1016/j.dib.2016.06.033] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2016] [Revised: 06/09/2016] [Accepted: 06/21/2016] [Indexed: 11/03/2022] Open
Abstract
Calcium/calmodulin-dependent kinase kinase 2 (CaMKK2) has been implicated in a range of conditions and pathologies from prostate to hepatic cancer. Here, we describe the expression in Escherichia coli and the purification protocol for the following constructs: full-length CaMKK2 in complex with CaM, CaMKK2 ‘apo’, CaMKK2 (165-501) in complex with CaM, and the CaMKK2 F267G mutant. The protocols described have been optimized for maximum yield and purity with minimal purification steps required and the proteins subsequently used to develop a fluorescence-based assay for drug binding to the kinase, “Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2” [1].
Collapse
Key Words
- AMPK, adenosine monophosphate-regulated kinase
- CaM, calmodulin
- CaMK, calcium/calmodulin-dependent kinase
- CaMKK2
- CaMKK2, calcium/calmodulin-dependent kinase kinase 2
- CaMKK2:CaM, CaMKK2-CaM complex
- Calmodulin
- E. coli, Escherichia coli
- Fermentation
- IPTG, β-D-1-thiogalactopyranoside
- LB, Luria broth
- LDS-PAGE, lithium dodecyl sulphate–polyacrylamide gel electrophoresis
- LIC, ligation-independent cloning
- OD, optical density
- PMSF, phenylmethylsulfonyl fluoride
- SEC, size-exclusion chromatography
- TEV, tobacco etch virus
- aa, amino acid
Collapse
Affiliation(s)
- Lisa Gerner
- Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Forskningsparken, University of Oslo and Oslo University Hospitals, 0349 Oslo, Norway
| | - Steffi Munack
- Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Forskningsparken, University of Oslo and Oslo University Hospitals, 0349 Oslo, Norway
| | - Koen Temmerman
- European Molecular Biology Laboratory Hamburg, Notkestrasse 85, 22603 Hamburg, Germany; European Molecular Biology Laboratory Heidelberg, Meyerhofstrasse 1, 69117 Heidelberg, Germany
| | - Ann-Marie Lawrence-Dörner
- European Molecular Biology Laboratory Heidelberg, Meyerhofstrasse 1, 69117 Heidelberg, Germany; Institute of Biochemistry, WWU Münster, Wilhelm-Klemm-Straße 2, 48149 Münster, Germany
| | - Hüseyin Besir
- European Molecular Biology Laboratory Heidelberg, Meyerhofstrasse 1, 69117 Heidelberg, Germany
| | - Matthias Wilmanns
- European Molecular Biology Laboratory Hamburg, Notkestrasse 85, 22603 Hamburg, Germany
| | - Jan Kristian Jensen
- Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus, Denmark
| | - Bernd Thiede
- Department of Biosciences, University of Oslo, Norway; Biotechnology Centre of Oslo, University of Oslo, Norway
| | - Ian G Mills
- Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Forskningsparken, University of Oslo and Oslo University Hospitals, 0349 Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospitals, Norway; Movember/Prostate Cancer UK Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology (CCRCB), Queen׳s University Belfast, UK
| | - Jens Preben Morth
- Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Forskningsparken, University of Oslo and Oslo University Hospitals, 0349 Oslo, Norway; Institute for Experimental Medical Research, Oslo University Hospital, Norway
| |
Collapse
|
4
|
Arora J, Hickey JM, Majumdar R, Esfandiary R, Bishop SM, Samra HS, Middaugh CR, Weis DD, Volkin DB. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody. MAbs 2016; 7:525-39. [PMID: 25875351 PMCID: PMC4622866 DOI: 10.1080/19420862.2015.1029217] [Citation(s) in RCA: 62] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
There is a need for new analytical approaches to better characterize the nature of the concentration-dependent, reversible self-association (RSA) of monoclonal antibodies (mAbs) directly, and with high resolution, when these proteins are formulated as highly concentrated solutions. In the work reported here, hydrogen exchange mass spectrometry (HX-MS) was used to define the concentration-dependent RSA interface, and to characterize the effects of association on the backbone dynamics of an IgG1 mAb (mAb-C). Dynamic light scattering, chemical cross-linking, and solution viscosity measurements were used to determine conditions that caused the RSA of mAb-C. A novel HX-MS experimental approach was then applied to directly monitor differences in local flexibility of mAb-C due to RSA at different protein concentrations in deuterated buffers. First, a stable formulation containing lyoprotectants that permitted freeze-drying of mAb-C at both 5 and 60 mg/mL was identified. Upon reconstitution with RSA-promoting deuterated solutions, the low vs. high protein concentration samples displayed different levels of solution viscosity (i.e., approx. 1 to 75 mPa.s). The reconstituted mAb-C samples were then analyzed by HX-MS. Two specific sequences covering complementarity-determining regions CDR2H and CDR2L (in the variable heavy and light chains, respectively) showed significant protection against deuterium uptake (i.e., decreased hydrogen exchange). These results define the major protein-protein interfaces associated with the concentration-dependent RSA of mAb-C. Surprisingly, certain peptide segments in the VH domain, the constant domain (CH2), and the hinge region (CH1-CH2 interface) concomitantly showed significant increases in local flexibility at high vs. low protein concentrations. These results indicate the presence of longer-range, distant dynamic coupling effects within mAb-C occurring upon RSA.
Collapse
Key Words
- ADCs, antibody-drug conjugates
- BS2G, bis (sulfosuccinimidyl) 2,2,4,4 glutarate
- BsAbs, bispecific antibodies
- CD, circular dichroism
- CDR, complementarity-determining regions
- CH1-CH3, constant domains 1–3 respectively of the heavy chain
- DLS, dynamic light scattering
- Fab, antigen binding fragment
- Fc, crystallizable fragment
- HC, heavy chain
- HPLC, high-performance liquid chromatography
- HX-MS, hydrogen exchange mass spectrometry
- IgG1, immunoglobulin G1
- LC, light chain
- RSA, reversible self-association
- SC, subcutaneous
- SEC, size-exclusion chromatography
- VH/VL, variable domain of the heavy/light chain
- aggregation
- flexibility
- high protein concentration
- hydrogen exchange
- immunoglobulin G1
- mAb, monoclonal antibody
- mass spectrometry
- monoclonal antibody
- protein-protein interactions
- reversible self-association
- stability
Collapse
Affiliation(s)
- Jayant Arora
- a Department of Pharmaceutical Chemistry; Macromolecule and Vaccine Stabilization Center; University of Kansas ; Lawrence , KS , USA
| | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Kaur P, Tomechko SE, Kiselar J, Shi W, Deperalta G, Wecksler AT, Gokulrangan G, Ling V, Chance MR. Characterizing monoclonal antibody structure by carboxyl group footprinting. MAbs 2016; 7:540-52. [PMID: 25933350 DOI: 10.1080/19420862.2015.1023683] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Structural characterization of proteins and their antigen complexes is essential to the development of new biologic-based medicines. Amino acid-specific covalent labeling (CL) is well suited to probe such structures, especially for cases that are difficult to examine by alternative means due to size, complexity, or instability. We present here a detailed account of carboxyl group labeling (with glycine ethyl ester (GEE) tagging) applied to a glycosylated monoclonal antibody therapeutic (mAb). The experiments were optimized to preserve the structural integrity of the mAb, and experimental conditions were varied and replicated to establish the reproducibility of the technique. Homology-based models were generated and used to compare the solvent accessibility of the labeled residues, which include aspartic acid (D), glutamic acid (E), and the C-terminus (i.e., the target probes), with the experimental data in order to understand the accuracy of the approach. Data from the mAb were compared to reactivity measures of several model peptides to explain observed variations in reactivity. Attenuation of reactivity in otherwise solvent accessible probes is documented as arising from the effects of positive charge or bond formation between adjacent amine and carboxyl groups, the latter accompanied by observed water loss. A comparison of results with previously published data by Deperalta et al using hydroxyl radical footprinting showed that 55% (32/58) of target residues were GEE labeled in this study whereas the previous study reported 21% of the targets were labeled. Although the number of target residues in GEE labeling is fewer, the two approaches provide complementary information. The results highlight advantages of this approach, such as the ease of use at the bench top, the linearity of the dose response plots at high levels of labeling, reproducibility of replicate experiments (<2% variation in modification extent), the similar reactivity of the three target probes, and significant correlation of reactivity and solvent accessible surface area.
Collapse
Key Words
- 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
- ACN, acetonitrile
- CD, circular dichroism
- CL, covalent labeling
- DR, dose response
- EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
- EIC, extracted ion chromatogram
- GEE, glycine ethyl ester
- HC, heavy chain
- HDX, hydrogen-deuterium exchange
- HRF, hydroxyl radical footprinting
- IT, ion trap
- IgG, immunoglobulin gamma
- LC, light chain
- Lys-C, lysyl endopeptidase
- MS, mass spectrometry
- RC, rate constant
- SASA, solvent accessible surface area
- SEC, size-exclusion chromatography
- acetonitrile
- circular dichroism
- covalent labeling
- dose response
- extracted ion chromatogram
- glycine ethyl ester
- heavy chain
- hydrogen-deuterium exchange
- hydroxyl radical footprinting
- immunoglobulin gamma
- ion trap
- light chain
- lysyl endopeptidase
- mAb, monoclonal antibody
- mass spectrometry
- monoclonal antibody
- rate constant
- size-exclusion chromatography
- solvent accessible surface area
Collapse
Affiliation(s)
- Parminder Kaur
- a Center for Proteomics and Bioinformatics; School of Medicine; Case Western Reserve University ; Cleveland , OH , USA
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Kaur P, Tomechko S, Kiselar J, Shi W, Deperalta G, Wecksler AT, Gokulrangan G, Ling V, Chance MR. Characterizing monoclonal antibody structure by carbodiimide/GEE footprinting. MAbs 2015; 6:1486-99. [PMID: 25484052 DOI: 10.4161/19420862.2014.975096] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Abstract
Amino acid-specific covalent labeling is well suited to probe protein structure and macromolecular interactions, especially for macromolecules and their complexes that are difficult to examine by alternative means, due to size, complexity, or instability. Here we present a detailed account of carbodiimide-based covalent labeling (with GEE tagging) applied to a glycosylated monoclonal antibody therapeutic, which represents an important class of biologic drugs. Characterization of such proteins and their antigen complexes is essential to development of new biologic-based medicines. In this study, the experiments were optimized to preserve the structural integrity of the protein, and experimental conditions were varied and replicated to establish the reproducibility and precision of the technique. Homology-based models were generated and used to compare the solvent accessibility of the labeled residues, which include D, E, and the C-terminus, against the experimental surface accessibility data in order to understand the accuracy of the approach in providing an unbiased assessment of structure. Data from the protein were also compared to reactivity measures of several model peptides to explain sequence or structure-based variations in reactivity. The results highlight several advantages of this approach. These include: the ease of use at the bench top, the linearity of the dose response plots at high levels of labeling (indicating that the label does not significantly perturb the structure of the protein), the high reproducibility of replicate experiments (<2 % variation in modification extent), the similar reactivity of the 3 target probe residues (as suggested by analysis of model peptides), and the overall positive and significant correlation of reactivity and solvent accessible surface area (the latter values predicted by the homology modeling). Attenuation of reactivity, in otherwise solvent accessible probes, is documented as arising from the effects of positive charge or bond formation between adjacent amine and carboxyl groups, the latter accompanied by observed water loss. The results are also compared with data from hydroxyl radical-mediated oxidative footprinting on the same protein, showing that complementary information is gained from the 2 approaches, although the number of target residues in carbodiimide/GEE labeling is fewer. Overall, this approach is an accurate and precise method for assessing protein structure of biologic drugs.
Collapse
Key Words
- ACN, acetonitrile
- CD, circular dichroism
- CL, covalent labeling
- DR, dose response
- EDC, 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
- EIC, extracts the ion chromatogram
- FPOP, fast photochemical oxidation of proteins
- GEE
- GEE, glycine ethyl ester
- HC, heavy chain
- HDX, hydrogen-deuterium exchange
- HRF, hydroxyl radical footprinting
- IT, ion trap
- IgG, immunoglobulin gamma
- LC, light chain
- LysC, Lysyl endopeptidase
- MS, mass spectrometry
- NMR, nuclear magnetic resonance
- RC, rate constant
- SASA, solvent accessible surface area
- SEC, size-exclusion chromatography
- VEGF, vascular endothelial growth factor
- covalent labeling
- footprinting
- mAb, monoclonal antibody
- protein structure
- structural proteomics
Collapse
Affiliation(s)
- Parminder Kaur
- a Center for Proteomics and Bioinformatics ; Case Western Reserve University ; Cleveland , OH USA
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Singh S, Kroe-Barrett RR, Canada KA, Zhu X, Sepulveda E, Wu H, He Y, Raymond EL, Ahlberg J, Frego LE, Amodeo LM, Catron KM, Presky DH, Hanke JH. Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody. MAbs 2015; 7:778-91. [PMID: 25905918 PMCID: PMC4622456 DOI: 10.1080/19420862.2015.1032491] [Citation(s) in RCA: 79] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Herein, we describe the generation and characterization of BI 655066, a novel, highly potent neutralizing anti-interleukin-23 (IL23) monoclonal antibody in clinical development for autoimmune conditions, including psoriasis and Crohn's disease. IL23 is a key driver of the differentiation, maintenance, and activity of a number of immune cell subsets, including T helper 17 (Th17) cells, which are believed to mediate the pathogenesis of several immune-mediated disorders. Thus, IL23 neutralization is an attractive therapeutic approach. Designing an antibody for clinical activity and convenience for the patient requires certain properties, such as high affinity, specificity, and solubility. These properties were achieved by directed design of the immunization, lead identification, and humanization procedures. Favorable substance and pharmacokinetic properties were established by biophysical assessments and studies in cynomolgus monkeys.
Collapse
Key Words
- ADCC, antibody-dependent cell-mediated cytotoxicity
- AUC, analytical ultracentrifugation
- BI 655066
- CCG, Chemical Computing Group
- CDRs, complementarity-determining regions
- CH, constant region
- Cκ, constant kappa
- DMF, dimethylformamide
- EOF, electro-osmotic flow
- ESI, electrospray ionization
- F, phenylalanine
- G, glycine
- GAHA, goat anti-human IgG gamma antibody
- HCLF, high concentration liquid formulation
- IL12, Interleukin 12
- IL12RB1, IL12 receptor subunit beta 1
- IL23, Interleukin-23
- IL23R, IL23 receptor
- JAK2, Janus kinase 2
- PBS, phosphate-buffered saline
- PK, pharmacokinetic
- RU, resonance units
- SEC, size-exclusion chromatography
- SPR, surface plasmon resonance
- Th17, T helper 17 cells
- UV, ultraviolet
- V, variable
- VH, variable heavy
- Vκ, variable kappa
- Y, tyrosine
- biophysical assessment
- humanization
- immunogen design
- pharmacokinetic profile
- tyk2, tyrosine kinase 2
Collapse
Affiliation(s)
- Sanjaya Singh
- a Department of Biotherapeutics Research; Boehringer Ingelheim Pharmaceuticals Inc. ; Ridgefield , CT , USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Zhang F, Zhang J, Liu M, Zhao L, LingHu R, Feng F, Gao X, Jiao S, Zhao L, Hu Y, Yang J. Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab. Oncoimmunology 2015; 4:e994391. [PMID: 25949918 DOI: 10.4161/2162402x.2014.994391] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2014] [Accepted: 11/27/2014] [Indexed: 01/06/2023] Open
Abstract
Although trastuzumab has succeeded in breast cancer treatment, acquired resistance is one of the prime obstacles for breast cancer therapies. There is an urgent need to develop novel HER2 antibodies against trastuzumab resistance. Here, we first rational designed avidity-imporved trastuzumab and pertuzumab variants, and explored the correlation between the binding avidity improvement and their antitumor activities. After characterization of a pertuzumab variant L56TY with potent antitumor activities, a bispecific immunoglobulin G-like CrossMab (Tras-Permut CrossMab) was generated from trastuzumab and binding avidity-improved pertuzumab variant L56TY. Although, the antitumor efficacy of trastuzumab was not enhanced by improving its binding avidity, binding avidity improvement could significantly increase the anti-proliferative and antibody-dependent cellular cytotoxicity (ADCC) activities of pertuzumab. Further studies showed that Tras-Permut CrossMab exhibited exceptional high efficiency to inhibit the progression of trastuzumab-resistant breast cancer. Notably, we found that calreticulin (CRT) exposure induced by Tras-Permut CrossMab was essential for induction of tumor-specific T cell immunity against tumor recurrence. These data indicated that simultaneous blockade of HER2 protein by Tras-Permut CrossMab could trigger CRT exposure and subsequently induce potent tumor-specific T cell immunity, suggesting it could be a promising therapeutic strategy against trastuzumab resistance.
Collapse
Key Words
- ADCC
- CDR, complementarity determining region
- CH1, constant heavy chain 1
- CL, constant light chain
- CRT, calreticulin
- CrossMab
- FCM, flow cytometry
- HER, human epidermal growth factor receptor
- HER2-ECD, extracellular domain of HER2
- HER2-overexpressing breast cancer
- LDH, lactate dehydrogenase
- PBMCs, peripheral blood mononuclear cells
- PI3K, phosphatidylinositol 3-kinase
- SEC, size-exclusion chromatography
- T cell immunity
- antibody-dependent cellular cytotoxicity
- calreticulin exposure
- mAb, monoclonal antibody
- pertuzumab
- trastuzumab
Collapse
Affiliation(s)
- Fan Zhang
- Department of Oncology; PLA General Hospital; PLA School of Medicine ; Beijing, People's Republic of China
| | - Jie Zhang
- Nursing Department; PLA General Hospital; PLA School of Medicine ; Beijing, People's Republic of China
| | - Moyan Liu
- Department of Nephrology; General Hospital of Jinan Military Command ; Jinan, People's Republic of China
| | - Lichao Zhao
- Medical Department; General Hospital of Jinan Military Command ; Jinan, People's Republic of China
| | - RuiXia LingHu
- Department of Oncology; PLA General Hospital; PLA School of Medicine ; Beijing, People's Republic of China
| | - Fan Feng
- Department of Pharmacy; General Hospital of Shenyang Military Command ; Shenyang, People's Republic of China
| | - Xudong Gao
- Department of Gastroenterology ; PLA 302 Hospital ; Beijing, People's Republic of China
| | - Shunchang Jiao
- Department of Oncology; PLA General Hospital; PLA School of Medicine ; Beijing, People's Republic of China
| | - Lei Zhao
- PLA General Hospital; PLA School of Medicine ; Beijing, People's Republic of China ; Institute for Translational Medicine; Second Military Medical University ; Shanghai, People's Republic of China
| | - Yi Hu
- Department of Oncology; PLA General Hospital; PLA School of Medicine ; Beijing, People's Republic of China
| | - Junlan Yang
- Department of Oncology; PLA General Hospital; PLA School of Medicine ; Beijing, People's Republic of China
| |
Collapse
|
9
|
Gao F, Lockyer K, Burkin K, Crane DT, Bolgiano B. A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components. Hum Vaccin Immunother 2014; 10:2744-53. [PMID: 25483488 PMCID: PMC4977451 DOI: 10.4161/hv.29696] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Physico-chemical analysis of pneumococcal polysaccharide (PS)-protein conjugate vaccine components used for two commercially licensed vaccines was performed to compare the serotype- and carrier protein-specific stabilities of these vaccines. Nineteen different monovalent pneumococcal conjugates from commercial vaccines utilizing CRM197, diphtheria toxoid (DT), Protein D (PD) or tetanus toxoid (TT) as carrier proteins were incubated at temperatures up to 56°C for up to eight weeks or were subjected to freeze-thawing (F/T). Structural stability was evaluated by monitoring their size, integrity and carrier protein conformation. The molecular size of the vaccine components was well maintained for Protein D, TT and DT conjugates at -20°C, 4°C and F/T, and for CRM197 conjugates at 4°C and F/T. It was observed that four of the eight serotypes of Protein D conjugates tended to form high molecular weight complexes at 37°C or above. The other conjugated carrier proteins also appeared to form oligomers or ‘aggregates’ at elevated temperatures, but rarely when frozen and thawed. There was evidence of degradation in some of the conjugates as evidenced by the formation of lower molecular weight materials which correlated with measured free saccharide. In conclusion, pneumococcal-Protein D/TT/DT and most CRM197 bulk conjugate vaccines were stable when stored at 2–8°C, the recommended temperature. In common between the conjugates produced by the two manufacturers, serotypes 1, 5, and 19F were relatively less stable and 6B was the most stable, with types 7F and 23F also showing good stability.
Collapse
Key Words
- CRM197, Cross-Reacting Material- 197
- DT, diphtheria toxoid
- F/T, freeze-thawing, HPAEC-PAD, high pH anion-exchange chromatography with pulsed amperometric detection
- HPAEC-PAD
- HPLC
- MW, molecular weight
- PD, Protein D
- PS, polysaccharide
- Pn, pneumococcal
- Protein D
- SEC, size-exclusion chromatography
- Streptococcus pneumoniae
- TT, tetanus toxoid
- conjugate vaccine
- fluorescence spectroscopy
- pneumococcal
- polysaccharide
- stability
Collapse
Affiliation(s)
- Fang Gao
- a Division of Bacteriology ; National Institute for Biological Standards and Control ; Hertfordshire , UK
| | | | | | | | | |
Collapse
|
10
|
Kilinc YB, Akdeste ZM, Koc RC, Bagirova M, Allahverdiyev A. Synthesis and characterization of antigenic influenza A M2e protein peptide-poly(acrylic) acid bioconjugate and determination of toxicity in vitro. Bioengineered 2014; 5:357-62. [PMID: 25482080 DOI: 10.4161/21655979.2014.969131] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
The influenza A virus is a critical public health problem that causes epidemics and pandemics, and occurs widely all over the world. Various vaccines against the virus have not provided a solution to the problem. Different approaches, particularly M2e peptide-based vaccines, are available for developing universal vaccines against influenza A. However, it is important to select a suitable carrier to obtain an effective vaccine. Accordingly, studies on the usage of various carriers are ongoing. Particularly, polymer-based carriers have gained importance due to both drug delivery and adjuvant effects. Therefore, bioconjugate of the M2e protein peptide from the influenza A virus covalent bonded with poly(acrylic) acid was synthesized in our study for the first time. The characterization was performed using size-exclusion chromatography and fluorescence spectroscopy; subsequently, it was found that the bioconjugate of the examined lower doses (0.05 and 0.5 mg/ml) have no toxic effects on human cell lines. These results suggest that, in the future, the poly(acrylic) acid bioconjugate of the M2e peptide should be studied in vivo for universal vaccine development against the influenza A virus.
Collapse
Key Words
- 7-ADD, 7-aminoactinomycin D
- BSA, bovine serum albumin
- DMEM-F12, dulbecco's modified eagle medium F12
- FBS, fetal bovine serum
- FITC, fluorescein isothiocyanate
- M2e
- M2e, The external domain of influenza A M2 protein
- MCF-7, human breast cancer cell
- MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- PAA, poly(acrylic) acid
- PBS, phosphate buffered saline
- Phe-P, phenylalanine
- RALS, right-angle light scattering
- SEC, size-exclusion chromatography
- Trp-W, tryptophan
- Try-Y, tyrosine
- UV, ultraviolet
- bioconjugate
- influenza A virus
- peptide
- poly(acrylic) acid
- synthetic vaccine
- toxicity
Collapse
Affiliation(s)
- Yasemin Budama Kilinc
- a Department of Bioengineering; Faculty of Chemical and Metallurgical Engineering ; Yildiz Technical University ; Esenler-Istanbul , Turkey
| | | | | | | | | |
Collapse
|
11
|
Ali I, Aboul-Enein HY, Singh P, Singh R, Sharma B. Separation of biological proteins by liquid chromatography. Saudi Pharm J 2010; 18:59-73. [PMID: 23960722 DOI: 10.1016/j.jsps.2010.02.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2009] [Accepted: 11/03/2009] [Indexed: 01/11/2023] Open
Abstract
After the success of human genome project, proteome is a new emerging field of biochemistry as it provides the knowledge of enzymes (proteins) interactions with different body organs and medicines administrated into human body. Therefore, the study of proteomics is very important for the development of new and effective drugs to control many lethal diseases. In proteomics study, analyses of proteome is essential and significant from the pathological point of views, i.e., in several serious diseases such as cancer, Alzheimer's disease and aging, heart diseases and also for plant biology. The separation and identification of proteomics is a challenging job due to their complex structures and closely related physico-chemical behaviors. However, the recent advances in liquid chromatography make this job easy. Various kinds of liquid chromatography, along with different detectors and optimization strategies, have been discussed in this article. Besides, attempts have been made to include chirality concept in proteomics for understanding mechanism and medication of various disease controlled by different body proteins.
Collapse
Key Words
- 2D-nano LC, two-dimensional nano liquid chromatography quadrupole
- ACN, acetonitrile
- AIEC, anion exchange chromatography
- CEC, capillary electro-chromatography
- CIEF, capillary isoelectric focusing
- CSF, cerebrospinal fluid
- Chirality
- EC, electro-chromatography
- ESI-LC–MS, electrospray ionization liquid chromatography–mass spectrometry
- FA, formic acid
- FLP, FMRF amide-like peptide
- FT-ICR-MS, ion cyclotron resonance-mass spectrometry
- GPI-APs, glycosylphosphadylinositol anchored proteins
- GSH, glutathione stimulating hormone
- GSTs, glutathione-S-transferase isoenzyme
- Gene
- HFBA, heptafluorobutyric acid
- HPLC, high performance liquid chromatography
- ICAT, isotope coded affinity tag
- IEF-SEC, isoelectrofocussing size-exclusion chromatography
- IMCD, inner medullary collecting duct
- LC-Q-TOF, liquid chromatography-quadrupole time-of-flight tandem mass
- LC-dual ESI, liquid chromatography dual electrospray ionization-Fourier transform
- LC–MS, liquid chromatography–mass spectrometry
- Liquid chromatography
- MALDI-TOF, matrix-assisted laser desorption/ionization-time-of flight
- MFGM, milk fat globule membranes
- MMA, mass measurement accuracy
- MPC, mesenchymal progenitor cell
- MS/MS, spectrometry
- NLFs, Nasal lavage fluids
- NLP, neuropeptide like protein
- Nano detection
- PC2, prohormone convertase-2
- PS II, photosystem II
- Preparation
- Proteomics
- Q-TOFMS/MS, time-of-flight tandem-mass spectrometry
- RPLC, reversed phase liquid chromatography
- SCX, strong cation exchange
- SEC, size-exclusion chromatography
- TFA, trifluoroacetic acid
- TIC, total ion current
- TRAF, tumor necrosis factor receptor
Collapse
Affiliation(s)
- Imran Ali
- Department of Chemistry, Jamia Millia Islamia (Central University), New Delhi 110 025, India
| | | | | | | | | |
Collapse
|